Arcus Biosciences Inc
NYSE:RCUS
Arcus Biosciences Inc
NYSE:RCUS
Price:
15.67 USD
-2.79%
Market Closed
Updated:
May 29, 2024
Arcus Biosciences Inc
Common Shares Outstanding
|
Arcus Biosciences Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arcus Biosciences Inc
NYSE:RCUS
|
Common Shares Outstanding
$90.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Arcus Biosciences Inc's Common Shares Outstanding?
Common Shares Outstanding
90.9m
USD
90.9m
USD
Based on the financial report for Mar 31, 2024, Arcus Biosciences Inc's Common Shares Outstanding amounts to 90.9m USD.
What is Arcus Biosciences Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
15%
15%
Over the last year, the Common Shares Outstanding growth was 24%. The average annual Common Shares Outstanding growth rates for Arcus Biosciences Inc have been 9% over the past three years , 15% over the past five years .
You don't have any saved screeners yet
